Caretropin

Phase:
Pre-registration -> Registration
Estimated Approval 2018 / 2019

Introduction

Identical to natural human growth hormone in structure and action, Caretropin is convenient to administer in its liquid cartridge type formulation using Daewoong's self-developed pen type syringe.

Composition

Somatropin.

Indication

Growth hormone deficiency.

Specification

22.5 IU and pen device.

Nabota

Phase:
Pre-registration -> Registration
Estimated Approval 2019

Introduction

Originated from wild-type clostridium botulinum, Nabota demonstrates superior purity derivered from its patented manufacturing process.

Composition

Botulinum toxin type A.

Indication

Glabellar lines, Post-stroke upper limb spasticity.

Specification

50IU/100IU/200IU, (1 Vial/ Box) Injection type

 

Luphere

Phase:
Pre-registration -> Registration
Estimated Approval 2020

Introduction

Luphere depot injection is a sustained release formulation of leuprorelin acetate
manufactured using Daewoong's proprietary patented spray-drying method which does not use gelatin in its manufacturing process.

Composition

Leuprorelin acetate

Indication

Prostate cancer, Endometriosis, Uterine myoma(fibroid), Central precocious puberty

Specification

Depot injection 1 month 3.75 mg, (1 Syringe/ Box).

Risenex plus

Phase:
Pre-registration -> Registration
Estimated Approval 2021

Introduction

Risenex plus is a new combination product of risedronate and cholecalciferol for osteoporosis treatment.

 

Composition

Risedronate / Cholecalciferol

Indication

Treatment and prevention of postmenopausal osteoporosis, Treatment of osteoporosis in men.

Specification

1 Blister x 4 tablets

Gliabrain

Phase:
Pre-registration -> Registration
Estimated Approval 2020

Introduction

Help memory function and cognitive health

Composition

Choline alfoscerate.

Specification

Box, 6 blister @ 15 tablet
Box, 2 blister @ 15 tablet
Box, 1 blister @ 15 tablet

Defezade

Phase:
Pre-registration
Estimated Approval 2021

Introduction

Exjade is an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions.

Composition

Deferasirox

Indication

transfusional
hemosiderosis

Specification

Box, 1 blister @ 30 tablet